New Eurasia patent

Solural Pharma ApS has received a decision to grant a Eurasia patent for the patent “Solid Oral Dosage Form of Lipophilic Compounds”.

New Manufacturing Authorisation

Solural Pharma receives an updated Manufacturing and Importation Authorisation from the Danish Health and Medicines Authority expanding its manufacturing capabilities to also include manufacturing of inhalation products as well as for physical chemical testing of...

New European patent

The European Patent office has announced a decision to grant Solural Pharma a European patent “Solid Oral Dosage Form of Lipophilic Compounds”.